Anti‐PD‐1 antibody camrelizumab plus doxorubicin showed durable response in pulmonary sarcomatoid carcinoma: Case report and literature review
2020 ◽
Vol 45
(6)
◽
pp. 1489-1496
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 8
(13)
◽
pp. 2876-2884
◽